Campaign Launches to Educate on HA Injectable Fillers
The initiative features a new report with data on consumer satisfaction and trends, aiming to correct misinformation for patients and providers.
The initiative features a new report with data on consumer satisfaction and trends, aiming to correct misinformation for patients and providers.
The cellulose-based dermal filler has received Health Canada authorization to begin clinical trials evaluating its safety and performance in tissue augmentation.
The botulinum toxin product from Hugel expands its global reach with training and launch events.